IL135943A0 - Hyperthermic inducible expression vectors for gene theraphy and methods of use thereof - Google Patents

Hyperthermic inducible expression vectors for gene theraphy and methods of use thereof

Info

Publication number
IL135943A0
IL135943A0 IL13594398A IL13594398A IL135943A0 IL 135943 A0 IL135943 A0 IL 135943A0 IL 13594398 A IL13594398 A IL 13594398A IL 13594398 A IL13594398 A IL 13594398A IL 135943 A0 IL135943 A0 IL 135943A0
Authority
IL
Israel
Prior art keywords
hyperthermic
methods
expression vectors
inducible expression
gene theraphy
Prior art date
Application number
IL13594398A
Original Assignee
Univ Arizona
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Arizona filed Critical Univ Arizona
Publication of IL135943A0 publication Critical patent/IL135943A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
IL13594398A 1997-11-03 1998-11-03 Hyperthermic inducible expression vectors for gene theraphy and methods of use thereof IL135943A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6408897P 1997-11-03 1997-11-03
PCT/US1998/023387 WO1999023216A2 (en) 1997-11-03 1998-11-03 Hyperthermic inducible expression vectors for gene therapy and methods of use thereof

Publications (1)

Publication Number Publication Date
IL135943A0 true IL135943A0 (en) 2001-05-20

Family

ID=22053477

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13594398A IL135943A0 (en) 1997-11-03 1998-11-03 Hyperthermic inducible expression vectors for gene theraphy and methods of use thereof

Country Status (9)

Country Link
EP (1) EP1029041A2 (en)
JP (1) JP2001521740A (en)
KR (1) KR20010031762A (en)
CN (1) CN1299411A (en)
AU (1) AU1377299A (en)
BR (1) BR9813917A (en)
CA (1) CA2308575A1 (en)
IL (1) IL135943A0 (en)
WO (1) WO1999023216A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19951765A1 (en) * 1999-10-27 2001-05-03 Thomas Schweder Host-vector systems for the overproduction of thermolabile enzymes in psychrophilic organisms
US6579522B1 (en) 2000-06-27 2003-06-17 Genvec, Inc. Replication deficient adenoviral TNF vector
CA2423833C (en) * 2000-09-26 2011-02-22 Emory University Viruses targeted to hypoxic cells and tissues
US7285414B2 (en) 2000-09-26 2007-10-23 Emory University Viruses targeted to hypoxic cells and tissues
US20030086903A1 (en) 2001-11-02 2003-05-08 Genvec, Inc. Therapeutic regimen for treating cancer
HUE025872T2 (en) 2002-06-18 2016-05-30 Eisai R&D Man Co Ltd Primary cultured adipocytes for gene therapy
AU2003278079A1 (en) * 2002-10-14 2004-05-04 Develogen Aktiengesellschaft Fur Entwicklungsbiologische Forschung Proteins involved in the regulation of energy homeostasis
JP2008048601A (en) * 2004-06-15 2008-03-06 Nippon Kosei Kagaku Kenkyusho:Kk Method for producing therapeutically useful product and system
WO2006116789A2 (en) * 2005-05-03 2006-11-09 Veterinärmedizinische Universität Wien Permeable capsules
JP2010540534A (en) * 2007-09-28 2010-12-24 イントレキソン コーポレーション Therapeutic gene switch constructs and bioreactors for the expression of biotherapeutic molecules and uses thereof
CN103667345B (en) * 2013-12-02 2015-10-28 东南大学 A kind of Antioncogene magnetic composite nano particle and preparation method
WO2017133175A1 (en) * 2016-02-04 2017-08-10 Nanjing Legend Biotech Co., Ltd. Engineered mammalian cells for cancer therapy
CN108913661A (en) * 2018-06-22 2018-11-30 安徽 A kind of preparation and extracting method of human research's candidate stem cell
CN114317588B (en) * 2020-09-29 2023-06-27 中国农业科学院生物技术研究所 Accurate methylation regulation and control return circuit of crop high temperature response formula genome
IT202200000788A1 (en) * 2022-01-19 2023-07-19 Bruno Cell S R L Temperature-sensitive induction of the myogenic and/or adipogenic program in cells producing muscle and/or adipose tissue
CN116536349B (en) * 2023-05-22 2024-02-20 安徽农业大学 Application of soybean GmMLP34 gene in regulation and control of high temperature resistance of plants

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3991770A (en) * 1974-01-24 1976-11-16 Leveen Harry H Method for treating benign and malignant tumors utilizing radio frequency, electromagnetic radiation
EP0299127A1 (en) * 1987-07-16 1989-01-18 IntraCel Corporation A method for the expression of recombinant genes under stimulation from an inducively expressed activator protein
EP0455424A3 (en) * 1990-05-02 1992-04-29 Merck & Co. Inc. Mammalian inducible promoter cascade system
FR2717187B1 (en) * 1994-03-10 1996-05-31 Transgene Sa Combined use of two expression cassettes for the production of a protein of interest.

Also Published As

Publication number Publication date
CA2308575A1 (en) 1999-05-14
EP1029041A2 (en) 2000-08-23
JP2001521740A (en) 2001-11-13
CN1299411A (en) 2001-06-13
AU1377299A (en) 1999-05-24
BR9813917A (en) 2001-10-30
WO1999023216A3 (en) 1999-08-05
WO1999023216A2 (en) 1999-05-14
KR20010031762A (en) 2001-04-16

Similar Documents

Publication Publication Date Title
IL135943A0 (en) Hyperthermic inducible expression vectors for gene theraphy and methods of use thereof
EP1037911A4 (en) Anti-pathogen system and methods of use thereof
AU1194802A (en) DNA expression vectors and methods of use
HUP0003852A3 (en) Use of highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias
PL321201A1 (en) Derivatives of 4-hydroxypiepridine, method of obtaining them and therapeutic agents containing such derivatives
PL110099U1 (en) Pair of hairdresser's scisors
IL123716A0 (en) New therapeutic combinations of mirtazepine and an antipsychotic agent
HUP9902655A3 (en) Pharmaceutical composition of hedgehog proteins and use thereof
GB2327190B (en) Process for the preparation of depilatory compositions and their use
EP0923642A4 (en) Active survival domains of igf-ir and methods of use
ZA955292B (en) Medical use of bromelain
AU4553793A (en) Use of p97 and iron binding proteins as diagnostic and therapeutic agents
HK1031128A1 (en) Jnk3 modulators and methods of use
AU6450398A (en) Sr-bi regulatory sequences and therapeutic methods of use
IL129593A0 (en) Novel constructs and vectors for the targeted and inducible expression of genes
EP1037669A4 (en) Therapeutic use of lentiviral vectors
HUP0000845A3 (en) Process for the preparation of iodinated contrast agents and intermediates therefor
HUP9800146A3 (en) Thalidomide-derivatives and use of them
AU5293198A (en) Promoter of the human endoglin gene and its use
IL126757A0 (en) Regulation of gene expression through manipulation of mRNA splicing and its uses
GB9800476D0 (en) Cosmetic composition for the treatment of the hair and/or the body
EP1070141A4 (en) Immediate early genes and methods of use therefor
AU2743097A (en) Simplified use of 5' ends of rnas for cloning and cdna library construction
EP1005360A4 (en) Antioxidant protein 2, gene and methods of use therefor
EP1015559A4 (en) Human regeneration-associated serpin-1 (rasp-1) and methods of use